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1140-165 Long-Term Statin Treatment Protects Against Nitrate-
Induced Oxidative Stress
Anne Otto, David Fontaine, Jeanine Fontaine, Guy Berkenboom, Institute of Pharmacy, 
ULB, Brussels, Belgium, Erasme Hospital, ULB, Brussels, Belgium
Background:Nitrate tolerance is associated with an enhanced superoxide anion produc-
tion and could be attenuated by statins as they interact with the two main (eNOS and
NAD(P)H oxidase) pathways involved in this oxidative stress.
Methods: 3 groups of normocholesterolemic rats were treated; group 1 received rosuvas-
tatin (10 mg/kg/d p.o) for 5 weeks and the last 3 days a cotreatment with the statin plus
nitroglycerin (NTG 50 mg/kg/d, sub-cutaneous injections b.i.d.); group 2 received only
NTG (50 mg/kg/d, b.i.d. for 3 days) and group 3 served as control. Rings of thoracic aor-
tas from these groups were studied in organ baths. Relaxations to NTG (0.1 nM to 0.1
mM) were determined on phenylephrine-preconstricted rings and O2- production
(counts/10s/mg) was assessed by lucigenin chemiluminescence technique.
Results: In group 2 (NTG), the concentration-response curves to NTG were significantly
shifted to the right : the pD2 (-log NTG concentration evoking a half maximal relaxation)
was 6.76+/-0.06 (n=7) vs 7.77+/-0.08 (n=7) in group 3 (not exposed to NTG, P<0.01) ;
O2- production was enhanced (289+/-23 (n=6) vs 183+/-34 (n=5, P<.05)). In contrast, in
group 1, the rightward shift was attenuated (pD2 values was 7.19+/-0.11 (n=8), P<.05 vs
group 2); O2- production was decreased : 208+/-19 (n=6, P<.05 vs group 2). In addition,
before NTG exposure, rosuvastatin treatment decreased p22phox (the essential
NAD(P)H subunit) abundance in aortic wall and NAD(P)H oxidase activity. In contrast,
this treatment did not alter either eNOS abundance or the basal release of endothelium-
derived NO.
Conclusion: Long-term rosuvastatin treatment protects against nitrate tolerance by coun-
teracting NTG-induced increase in O2- production. This protection seems to involve a
direct interaction with the NAD(P)H oxidase pathway rather than an upregulation of the
eNOS pathway.
1140-166 Enhancing Arteriogenesis Increases Atherosclerosis 
and Reducing Atherosclerosis Reduces Arteriogenesis: 
Demonstration of the Concept in Mice
Mary Susan Burnett, Tim Kinnaird, Eugenio Stabile, Cheol Whan Lee, Matie Shou, 
Stephen E. Epstein, MedStar Research Institute, Washington, DC
Background: Inflammatory and immune cells are known to contribute to atherogenesis.
We and others have reported data indicating that such cells also enhance collateral
development. We have used two mouse models with different predispositions to both ath-
erosclerosis and collateral development to gain insight into this “trade-off” phenomenon.
It is our hypothesis that: Shared inflammatory mechanisms contribute to atherogenesis
and to arteriogenesis; stimulating these pathways will activate both processes. Consider-
ation of these findings will be important in developing clinical strategies designed to
enhance collaterals or prevent atherosclerosis in patients.
Methods: Aortic lesion area was assessed in 16 week, chow fed Balb/c and C57BL/6J
ApoE-/- mice (n=20) using Oil Red O staining and computer assisted morphometric anal-
ysis. Total serum cholesterol was quantified. To examine collateral development, at 12
weeks, C57BL/6J and Balb/c animals (n=10) underwent left femoral artery ligation. Flow
recovery was assessed using Laser Doppler Perfusion Imaging over a 4 week period and
expressed as a ratio of ischemic to normal limb flows. 
Results: The C57BL/6J ApoE -/- mice had greater lesion area when compared to Balb/c
ApoE-/- mice, although the Balb/c ApoE-/- mice had higher serum cholesterol levels.
[C57BL/6J ApoE -/- vs. Balb/c ApoE-/-: Lesion area (µm2) ; 22,081 +/-2646 vs. 8062 +/-
1429, p< 0.0001, cholesterol levels (mg/dl); 840+/-49 vs. 960 +/-38, p<0.039]. Blood flow
recovery was significantly better in C57BL/6J compared to Balb/C [0.652 vs 0.306 at day-
7, 0.806 vs 0.519 at day-28, p<0.001 for trend by ANOVA]. 
Conclusions: The C57BL/6J mouse is more susceptible to atherosclerosis than the
Balb/c strain; however, the C57BL/6J strain exhibits a marked improvement in collateral
flow during recovery from femoral artery ligation that is not observed in the Balb/c mouse.
These data support our hypothesis that shared mechanisms contribute to both athero-
sclerosis and arteriogenesis, and set the stage for future studies to examine this “trade-
off” phenomenon in greater detail.
1140-167 Cytomegalovirus Impairs Endothelial Nitric Oxide 
Synthase Pathway: Role of Oxidative Stress and Viral 
Entry
Katsuya Iijima, Satoshi Noda, Karsten Sydow, Edward S. Mocarski, John P. Cooke, 
Stanford University School of Medicine, Palo Alto, CA
Background: Seroepidemiological and histopathological evidence has implicated CMV in
pathogenesis of atherosclerosis. We hypothesized CMV may accelerate atherogenesis
by impairing endothelial nitric oxide synthase (NOS) pathway. An important determinant
of NOS activity is ADMA (asymmetric dimethylarginine), an endogenous inhibitor of
NOS. Methods and Results: To determine whether CMV impairs the NOS pathway by
increasing ADMA accumulation, cultured human microvascular endothelial cells (EC)
were infected with endotheliotrophic human CMV strain, TB40/E, at MOI 1, 3, and 10.
HPLC analysis of the conditioned medium showed a dose-dependent increase in ADMA
accumulation. The increase in ADMA was associated with a decline in intracellular cGMP
(by 43%) indicating inhibition of the NOS pathway. We hypothesized accumulation of
ADMA was due to its impaired degradation by enzyme dimethylarginine dimethylamino-
hydrolase (DDAH). Indeed, the CMV-induced increase in ADMA after 72h infection was
temporally associated with a marked reduction (over 80%) in DDAH activity, which is
impaired by oxidative stress. CMV dose- and time-dependently increased generation of
intracellular O2-derived free radicals using FACS analysis and a fluorescent marker,
DCFDA. Surprisingly, the CMV-induced increase of oxidative stress did not require viral
replication because UV-inactivated virus induced the same response, but did require
binding and entry of viral particles because neutralizing antibody to the virus blocked its
effects to increase ADMA. Tegument proteins carried by CMV are known to modulate
immunological response in infected cells, and could be responsible for the observed
effects. One of these proteins, phosphoprotein 65, was detected within EC by immunoflu-
orescent staining even after exposure to UV inactivated virus. Conclusion: CMV infection
impairs the NOS pathway by inducing an oxidative impairment of DDAH which leads to
accumulation of the NOS inhibitor ADMA. This effect of CMV on EC does not require viral
gene replication, but does require viral binding and entry, suggesting release of one or
more viral tegument proteins after viral entry may be responsible for derangement of the
NOS pathway.
1140-168 In Vivo Caspase-Inhibition Prevents Plaque Progression 
by Reducing Apoptosis and Tissue-Factor Expression 
in a Mouse Model of Chronic Atherosclerosis
Randolph Hutter, Carolina Valdiviezo, Gurusher Panjrath, Bernhard Sauter, Francine 
Carrick, Valentin Fuster, Juan Jose Badimon, Mount Sinai School of Medicine, New York, 
NY
Background: Lipid lowering therapy has been shown to reduce thrombogenicity of ath-
erosclerotic plaques. Inflammatory cells undergoing apoptosis when exposed to ox-LDL
in lipid-rich plaque can contribute to plaque thrombogenicity via synthesis of tissue-factor
(TF). Therefore, increased intimal apoptosis and tissue-factor expression could be a key
factor for accelerating plaque progression. To test this hypothesis we evaluated the effect
of caspase-inhibition (CI) in a mouse model of atherosclerosis in vivo.
Methods: Apo-E -/- mice (n=13) were fed a Western Diet for 7 months. Three animals
were sacrificed at 7 month and served as baseline control (BL). The remaining animals
were randomized into treatment (TR) (n=5) and control group (CT) (n=5) receiving either
3 weeks of continuous CI (daily i.p. injection of 30 mcg/kg of Q-VD-OPH general
caspase-inhibitor in 50 mcl DMSO) (n=5) or DMSO treatment alone (n=5) (data as
mean±SEM). Plasma cholesterol levels were similar in all groups with 780±58mg/dl for
the BSL group, and 958±64mg/dl and 854±56mg/dl for the TR and CT group. Atheroscle-
rosis was assessed by (immuno)histo-morphometric analysis of the aortic root and by
Sudan IV stainings of whole-mounted abdominal aorta.
Results: CI significantly reduced plaque size compared to controls (0.59±0.05 vs.
0.88±0.04, P<.01). Lipid deposition (Sudan IV) of abdominal aorta was also significantly
reduced by CI compared to CT and BSL. Expression of both aCS-3 and TF in intimal
cells was significantly reduced by CI compared to CT and BSL (aCS3: 9%±2 vs. 30%±3,
P<.01; 9%±2 vs. 23%±3, P<.01; TF: 15%±2 vs. 41%±3, P<.01, 15%±2 vs. 43%±5,
P<.01) and correlated positively with plaque size (P<.05). Double-labeling demonstrated
co-localization of TF and aCS-3.
Conclusion: CI inhibited plaque progression and reversed the increased intimal expres-
sion of both apoptosis and TF despite persistently elevated blood lipid levels. These find-
ings point to intimal apoptosis and associated tissue-factor expression as a possible final
common pathway involved in plaque progression. Therefore, CI could be a powerful tool
to protect intimal cells from diverse pro-apoptotic stimuli leading to a better treatment of
atherosclerosis.
1140-169 Heavy Coronary Plaque Calcification Is Associated With 
Only Minor Degrees of Plaque Macrophage and 
Neovessel Density Than Plaques With Less 
Calcification: Solving the Calcium Paradox?
Silvio Litovsky, Deborah Vela, Allen Burke, Mohammad Madjid, Morteza Naghavi, Saeed 
Payvar, Renu Virmani, Ward Casscells, Texas Heart Institute, Houston, TX, Armed 
Forces Institute of Pathology, Washington, DC
Background. Carotid symptomatic plaques are usually severely calcified. There is
greater variability in that respect with the coronary arteries especially in cases of thin cap
fibroatheromas leading to cap ruptures, where severe calcification may occur but is not
the norm. In the present work we compared plaques with heavy calcification with plaques
with less calcification with regards to macrophage infiltration and neovascularization. 
Methods. Coronary artery section from ten patients with plaque ruptures and of ten
patients with fibrocalcific plaques were obtained from the Armed Forces Institute of
Pathology files. Plaques were routinely decalcified prior to processing. We performed
immunohistochemistry for detection of neovascularization with the endothelial cell mark-
ers factor VIII and for macrophages with the Kp-1 marker. Morphometric computerized
analysis was performed with Olympus MicroSuite software
Results. When the calcification was mild, not reaching the superficial third of the plaque,
it coexisted with a lipid necrotic core and was accompanied by a significant macrophage
infiltration in the plaque and neovascularization (the latter more prominent in the underly-
ing media and adventitia). Areas of heavy calcification (even in the same cross-section)
were associated with loss of lipid core, decrease to almost absence of macrophages and
neovessels density.
Conclusion. The study suggests a plausible explanation for the apparent paradox of cal-
cium being a marker of plaque vulnerability and at the same time providing protection to
the plaque. Mild/moderate calcification is associated with known markers of vulnerable
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plaque: large lipid core, extensive macrophage density and neoangiogenesis. Large
areas of calcification, on the other hand, have lower (or absent) lipid cores, macrophage
and angiogenesis density.
1140-170 Hydrogen Peroxide-Induced Superoxide Production in 
Endothelial Cells: Role of Nitric Oxide Synthase
Christian H. Coyle, Neal L. Weintraub, Khalid N. Kader, University of Iowa, Iowa City, IA, 
University of Iowa Hospitals and Clinics, Iowa City, IA
Background: Hydrogen peroxide causes oxidant injury to vascular cells and may con-
tribute to the pathogenesis of vascular disease and endothelial dysfunction. In smooth
muscle cells (SMC), hydrogen peroxide causes oxidant injury via NAD(P)H oxidase-
dependent production of superoxide and superoxide scavengers protect against hydro-
gen peroxide-induced SMC cytotoxicity. We investigated the potential enzymatic sources
and consequences of hydrogen peroxide-induced superoxide production in quiescent
endothelial cells and in cells exposed to physiologic shear.
Methods: Superoxide production was examined by dihydroethidium fluorescence. Nitric
oxide production was quantified via Greiss assay and intracellular staining with DAF-FM
diacetate. Cell viability was determined by propidium iodide staining, and cell detachment
was assessed under static and shear conditions.
Results: Under static conditions, 60 µM hydrogen peroxide induced superoxide produc-
tion in porcine aortic endothelial cells (PAEC). In the presence of L-NAME (1 mM), a spe-
cific inhibitor of nitric oxide synthase (NOS), there was a sixty percent reduction in
cellular superoxide production (n=9, p=0.001). Apocynin (0.5 mM), an inhibitor of
NAD(P)H oxidase, combined with L-NAME (1 mM) was also found to reduce superoxide
production. Manganese superoxide dismutase (MnSOD) overexpression by adenoviral-
mediated gene transfer reduced hydrogen peroxide-induced superoxide levels seventy-
five percent under static (n=12, p-value less than 0.001) and forty-seven percent under
physiological shear (n=4, p=0.03) conditions as assayed by hydroethidium fluorescence.
Hydrogen peroxide induced endothelial cytotoxicity and detachment under static and
shear conditions, which was reduced by MnSOD overexpression or L-NAME or the com-
bination of L-NAME and Apocynin.
Conclusions: In conclusion, in culture and shear-exposed PAEC, hydrogen peroxide
induces production of superoxide, which contributes to cytotoxicity in these cells. eNOS
appears to be an important enzymatic source of hydrogen peroxide-induced superoxide
production in PAEC.
1140-171 Elevated Gene Expression of Asymmetric 
Dimethylarginine-Generating Enzymes in 
Atherosclerosis
Christiane P. Tiefenbacher, Chen Xiaobo, University of Heidelberg, Heidelberg, Germany
Background. Endothelial function is altered early in the course of atherosclerosis result-
ing in reduced biological activity of nitric oxide. NO-synthase I-III as well as GTPCH–1
(formation of tetrahydrobiopterin, an essential cofactor of all NO-synthase isoforms) con-
tribute to the generation of NO. Arginase I and II reduce L-arginine, the substrate of NO.
PRMT I - III contribute to the synthesis of ADMA (inhibitor of NO-synthase) whereas
DDAH2 reduces ADMA. SOD I - III and p22phox, a subunit of NADPH oxidase, are
involved in the metabolism of oxygen free radicals. We hypothesized that alterations in
the gene expression of these enzymes is involved in the reduction of NO-availability in
atherosclerosis.
Methods. Gene and protein expression were determined by western blot and real-time
PCR in human myocardium from patients with and without atherosclerosis.
Results. All enzymes could be detected in myocardial tissue. Whereas expression of
p22phox, SOD I-III as well as arginase I and II and PRMTII was unaltered in atheroscle-
rotic tissue, expression of all NO-synthase isoforms as well as DDAH2 was significantly
decreased. In contrast, the level of PRMTI and III was increased in tissue from patients
with atherosclerosis.
Conclusion. In myocardial tissue from patients with atherosclerosis, acitivity of NO-syn-
thase is severely decreased. Additionally, an enhanced activity of PRMT in combination
with lower activity of DDAH2 could induce an increased formation of ADMA, a potent
inhibitor of NO-synthase. The altered gene expression pattern as observed in our investi-
gation could contribute to the known reduction of NO-availability in atherosclerosis.
1140-172 Sulfatides Are Targets for Antiphospholipid Antibodies
Michael Merten, Frank C. Arnett, Perumal Thiagarajan, Baylor College of Medicine, 
Houston, TX, University Clinic of Hamburg-Eppendorf, Hamburg, Germany
Background Sulfatides are sulfated glycosphingolipids expressed on the surface of
erythrocytes, leukocytes and platelets. Sulfatides interact with several cell adhesion mol-
ecules involved in hemostasis. β2-glycoprotein I is an anionic phospholipid-binding
plasma protein and the phospholipid-bound form is the target for most antiphospholipid
antibodies that are associated with recurrent thrombosis, miscarriages and neurological
symptoms. In this study, we examined whether β2-glycoprotein I forms a complex with
sulfatides, and thereby becomes a target for antiphospholipid antibodies.
Methods We used ELISA-assays for the binding studies, and spectrophotometry to mea-
sure vesicle aggregation. Anticardiolipin antibodies were isolated by immunoaffinity puri-
fication, β2-glycoprotein I was isolated by gel filtration.
Results β2-glycoprotein I bound saturably to surface-bound sulfatides, but not to other
glycolipids such as ceramide, cerebrosides, sphingomyelin or ganglioside. At a sulfatide
coating density of 1 µg/well, β2-glycoprotein I reached half-maximal binding at 2.5 µg/ml
and the binding saturated at 10 µg/ml. The binding of β2-glycoprotein I also depended on
the coating density of sulfatides in the well. At a constant β2-glycoprotein I concentration
of 5 µg/ml, maximal binding of β2-glycoprotein I was observed at a sulfatide coating den-
sity of 1 µg/well. β2-glycoprotein bound also to vesicles containing sulfatides and aggre-
gated these vesicles in a concentration-dependent manner. Furthermore, we examined
the sera of 14 patients with anticardiolipin antibodies, a subset of antiphospholipid anti-
bodies, for their binding to sulfatide-bound β2-glycoprotein I. All of these sera interacted
with sulfatide-bound β2-glycoprotein I as efficiently as with cardiolipin-bound β2-glyco-
protein I. In addition, some of these patients have antibody species that are specific for
sulfatide-β2-glycoprotein I complex.
Conclusion These results show that not only anionic phospholipids, as commonly
known, but also sulfatides are targets for antiphospholipid antibodies, thereby possibly
contributing to some of the clinical symptoms of the antiphospholipid syndrome.
1140-173 Fibrates Inhibit Plasminogen Activator Inhibitor Type-1 
Expression in Human Adipose Tissue: An 
Antiatherogenic Phenomenon?
Andreas Zirlik, Anne Leugers, Sandra Ernst, Christoph Bode, Burton E. Sobel, Thomas 
K. Nordt, University of Freiburg, Freiburg, Germany, University of Vermont College of 
Medicine, Burlington, VT
Background: Plasminogen Activator Inhibitor Type-1 (PAI-1) is an independent risk factor
for cardiovascular disease and is extensively produced by adipose tissue. Fibrates are
lipid lowering agents activating peroxisome proliferator activated receptor-alpha (PPAR-
α). Recent experimental as well as clinical data attributed additional antiatherosclerotic
properties to these substances. The mechanisms, however, remain to be fully under-
stood. The current study investigates a possible modulation of PAI-1 expression in adi-
pose tissue by fibrates.
Methods: Human preadipocytes in primary culture were exposed to selected concentra-
tions of gemfibrocil and fenofibrate (100, 350, 700µM) in the presence or absence of
40pM transforming growth factor-beta (TGF-β)), an established stimulus for PAI-1 expres-
sion. PAI-1 protein was measured by ELISA, PAI-1 mRNA by light cycler RT-PCR. Paral-
lel experiments were performed in cultures of differentiated human adipocytes.
Results: In both cell fractions of human adipose tissue, in preadipocytes and adipocytes,
gemfibrocil and fenofibrate reduced PAI-1 protein expression by up to 39±10% (n=6,
P=0.01) and 27±8% (n=6, P=0.01) under basal conditions and up to 35±6% (n=6,
P=0.001) and 18±5% (n=6, P=0.04) when stimulated with 40pM TGF-β. Coincubation of
350µM gemfibrocil and 5µM troglitazone, a PPAR-γ agonist known to downregulate PAI-1
expression in adipose tissue, did not produce an additional effect compared to either of
the substances alone suggesting a common final pathway (n=4, P=n.s.). Time course
experiments showed a maximal effect after 24 hours (n=3, P<0.05 each). Total protein
quantification indicated persistant viability of cells. Quantification of mRNA proofed that
regulation was at least in part at the transcriptional level (n=3, P<0.01 each). Incubation
with nonfibrate PPAR-α agonists showed similar reductions in PAI-1 expression suggest-
ing that effects were mediated by PPAR-α (n=3, P<0.05, each) and not merely pleiotro-
pic.Conclusions: Our data support the view that PPAR-α activation is an
antiatherosclerotic phenomenon that may diminish cardiovascular risk, possibly by down-
regulation of PAI-expression in adipose tissue.
1140-174 Enhanced Expression of Pro-Oxidant Enzyme 
Myeloperoxidase Is Associated With Plaque 
Destabilization in Human Coronary Atherosclerotic 
Lesions
Ryushi Komatsu, Takahiko Naruko, Akira Itoh, Kazuo Haze, Nobuyuki Shirai, Eishu Hai, 
Yoshihiro Ikura, Masahiko Ohsawa, Makiko Ueda, Osaka City General Hospital, Osaka, 
Japan, Osaka City University Graduate School of Medicine, Osaka, Japan
Background: Presently, a growing body of literature have shown that inflammation and
oxidative stress in coronary atherosclerotic lesions relate to rapidly progressive plaque
destabilization. We have recently demonstrated that neutrophils play a role in mediating
destabilization of atherosclerotic plaques (Naruko T et al, Circulation 106, 2002). Recent
studies have demonstrated the presence of active pro-oxidant enzyme myeloperoxidase
(MPO) and products of MPO-mediated reaction in human atherosclerosis. To investigate
the potential significance of MPO in human coronary atherosclerosis, we immunohis-
tochemically studied the expression of MPO in human coronary atherosclerotic lesions.
.Methods: Frozen sections of normal coronary artery segments (Normal, n=26), and cor-
onary atherosclerotic segments (n=74) with fibrolipid plaque (FLP; n=31), fibrous plaque
(FP; n=30) , ruptured plaques (RP; n=8), and eroded plaques (EP; n=5) were stained
with antibodies against smooth muscle cells, macrophages, endothelial cells, MPO and
neutrophils(CD66b, CD11b, and elastase). We used computer-aided planimetry which
quantified the immunoreactivity of macrophages, neutrophils and MPO positive area.
Moreover for the identification of cell types which stain positive for MPO, immunodouble
staining with MPO and macrophages or MPO and neutrophils was also performed.
Results: Quantitative analysis demonstrated that neutrophil, macrophages, or MPO posi-
tive area was significantly (P<0.0001) higher in EP and RP than in FLP, and FP. Immun-
odoublestaining for MPO and neutrophils or macrophages revealed that the majority of
MPO-positive cells were neutrophils, and occasional macrophages were also positive for
MPO. Conclusions: These findings strongly suggest that strong expression of MPO posi-
tive neutrophils plays an important role in the pathogenesis of plaque destabilization in
human coronary arteries.
1140-175 Hypoxia Increased Matrix Metalloproteinase Activity 
and Superoxide Formation Before Atherosclerosis in 
Female Artery of Apolipoprotein E-Knockout Mice
Nobuaki Okuda, Tetsuya Hayashi, Tatsuhiko Mori, Koichi Sohmiya, Sakiko Inamoto, 
Yasushi Kitaura, Naoko Tazawa, Daisuke Nakano, Yasuo Matsumura, Osaka Medical 
College, Takatsuki, Japan
Background: Arterial wall hypoxia and the associated vascular smooth muscle cell prolif-
eration might be implicated in the development of atherosclerosis. To evaluate the effect
of hypoxia on the artery before atherosclerosis, we examined matrix metalloproteinase
